Skip to main content
Macular Disease Foundation Australia
  • My Cart
  • Text Only
  • Listen
  • Print Page
  • Language
    • English
    • Arabic
    • Chinese
    • Greek
    • Italian
    • Portuguese
    • Spanish
    • Vietnamese
  • Search form

Check My Macula Check My Macula Join the Community Join the Community Order Free Information Order Free Information Call our helpline at 1800111709 Helpline
1800 111 709
Donate Donate
  • Home
  • Macular Disease
    • Macular Degeneration
      • About Macular Degeneration
      • Check My Macula
      • What Happens?
      • Risk Factors
      • Prevention
      • Detection
      • Diagnosis
      • Treatment
      • Charles Bonnet Syndrome
      • Cataracts and Macular Degeneration
      • Frequently Asked Questions
    • Diabetic Retinopathy
      • About Diabetic Retinopathy
      • About Diabetes
      • What Happens?
      • Risk Factors
      • Prevention
      • Detection
      • Diagnosis
      • Treatment
      • Frequently Asked Questions
    • Low Vision
      • Living with Low Vision
      • Carer and Family
      • Aids and Technology
      • Slips, Trips and Falls
      • Legal blindness
    • Other Macular Diseases
      • Best Disease
      • Macular Hole
      • Macular Pucker
      • Macular Telangiectasia
      • Myopic Macular Degeneration
      • Retinal Detachment
      • Retinitis Pigmentosa
      • Retinal Vein Occlusion
      • Stargardt Disease
      • Central Serous Chorioretinopathy (CSC)
      • Posterior Vitreous Detachment and Floaters
      • Vitreomacular Traction Syndrome
    • Visit Eye Health Professional
      • Eye Injection Costs and Rebates
    • Macular Disease
      • Anti-VEGF injections for macular disease
  • Research
    • Research Grants Program
      • Research Grants Awarded
      • Research Grant Recipients
      • Apply for the 2021 MDFA Research Grants Program
      • Research Grants Panel
    • Support Research
    • Latest Research
      • Research News
      • MDFA Research
      • Macular Diseases
      • Understanding Research
      • Social Impact
    • Research Updates
      • Annual Research Update
      • Weekly Research Updates for Professionals
    • Research studies
      • Research participants needed in the Canberra region who enjoy art and have vision loss
  • Resources
    • Order Publications and Resources
    • Find a Healthcare Provider
    • Audio and Video
      • Audio
      • Podcasts
      • Patient Voices
      • Videos
    • Macula Menus
    • Check My Macula toolkits
    • Aged care resources
  • News & Events
    • Newsletters
      • Vision Voice Newsletters
      • Subscribe to Newsletters
      • Archive
    • News
      • 2021 news
      • 2020 news
      • 2019 News
      • 2018 News
      • 2017 News
      • 2016 News
      • Archived News
    • Events & Activities
      • Community Events
      • Education Sessions
      • Events Calendar
      • Watch past webinars
    • Media Centre
      • Media Releases
  • Foundation
    • Organisation
      • History
      • Objectives
      • Guiding Principles
      • Annual Reports
      • Whistleblower Policy
      • Financial Statements
    • People
      • Patron
      • State Patrons / Representatives
      • Ambassadors
      • Foundation Board
      • Committees
      • State Chairs
      • National Research Advisor
    • Our Work
      • Awareness
      • Education
      • Support Services
      • Research
      • Representation
    • Support Us
      • Donate
      • Bequests
      • Fundraise
      • Volunteer
      • Friends of the Foundation
      • Sponsors and Supporters
      • Professional Friends
    • Contact Us
Listen
Macular Disease Foundation Australia
Check My Macula Macula Join the Community Join Us Order Free Information Free Info Donate Donate
Menu
  • My Cart
    • Language
      • English
      • Arabic
      • Chinese
      • Greek
      • Italian
      • Portuguese
      • Spanish
      • Vietnamese
    • Home
    • Macular Disease
      • Macular Degeneration
        • About Macular Degeneration
        • Check My Macula
        • What Happens?
        • Risk Factors
        • Prevention
        • Detection
        • Diagnosis
        • Treatment
        • Charles Bonnet Syndrome
        • Cataracts and Macular Degeneration
        • Frequently Asked Questions
      • Diabetic Retinopathy
        • About Diabetic Retinopathy
        • About Diabetes
        • What Happens?
        • Risk Factors
        • Prevention
        • Detection
        • Diagnosis
        • Treatment
        • Frequently Asked Questions
      • Low Vision
        • Living with Low Vision
        • Carer and Family
        • Aids and Technology
        • Slips, Trips and Falls
        • Legal blindness
      • Other Macular Diseases
        • Best Disease
        • Macular Hole
        • Macular Pucker
        • Macular Telangiectasia
        • Myopic Macular Degeneration
        • Retinal Detachment
        • Retinitis Pigmentosa
        • Retinal Vein Occlusion
        • Stargardt Disease
        • Central Serous Chorioretinopathy (CSC)
        • Posterior Vitreous Detachment and Floaters
        • Vitreomacular Traction Syndrome
      • Visit Eye Health Professional
        • Eye Injection Costs and Rebates
      • Macular Disease
        • Anti-VEGF injections for macular disease
    • Research
      • Research Grants Program
        • Research Grants Awarded
        • Research Grant Recipients
        • Apply for the 2021 MDFA Research Grants Program
        • Research Grants Panel
      • Support Research
      • Latest Research
        • Research News
        • MDFA Research
        • Macular Diseases
        • Understanding Research
        • Social Impact
      • Research Updates
        • Annual Research Update
        • Weekly Research Updates for Professionals
      • Research studies
        • Research participants needed in the Canberra region who enjoy art and have vision loss
    • Resources
      • Order Publications and Resources
      • Find a Healthcare Provider
      • Audio and Video
        • Audio
        • Podcasts
        • Patient Voices
        • Videos
      • Macula Menus
      • Check My Macula toolkits
      • Aged care resources
    • News & Events
      • Newsletters
        • Vision Voice Newsletters
        • Subscribe to Newsletters
        • Archive
      • News
        • 2021 news
        • 2020 news
        • 2019 News
        • 2018 News
        • 2017 News
        • 2016 News
        • Archived News
      • Events & Activities
        • Community Events
        • Education Sessions
        • Events Calendar
        • Watch past webinars
      • Media Centre
        • Media Releases
    • Foundation
      • Organisation
        • History
        • Objectives
        • Guiding Principles
        • Annual Reports
        • Whistleblower Policy
        • Financial Statements
      • People
        • Patron
        • State Patrons / Representatives
        • Ambassadors
        • Foundation Board
        • Committees
        • State Chairs
        • National Research Advisor
      • Our Work
        • Awareness
        • Education
        • Support Services
        • Research
        • Representation
      • Support Us
        • Donate
        • Bequests
        • Fundraise
        • Volunteer
        • Friends of the Foundation
        • Sponsors and Supporters
        • Professional Friends
      • Contact Us
  • Home
  • Foundation
  • Our Work
  • Representation
  • Submissions
  • Archived submissions
Back

Foundation

  • Organisation
    • History
    • Objectives
    • Guiding Principles
    • Whistleblower Policy
    • Annual Reports
    • Financial Statements
  • People
    • Patron
    • State Patrons / Representatives
      • Western Australian State Patron
      • Victorian State Patron
      • Tasmanian State Patron
      • South Australian Custodian of Vision
    • Ambassadors
      • Jean Kittson
      • Jan Utzon
    • Foundation Board
      • Robert Kaye
      • Associate Professor Alex Hunyor
      • Brigadier John Fenwick
      • Richard Grills
      • Lisa Lusthaus
      • Imelda Lynch
      • Neil Wykes
    • Committees
    • State Chairs
    • National Research Advisor
  • Our Work
    • Awareness
      • Macula Month
        • mEYE World Photographic Competition
          • Winners
          • Categories
          • Prizes
          • Judges
          • Sponsors and Supporters
          • Frequently Asked Questions
          • Terms and Conditions
          • 2016 mEYE World Photographic Competition
          • 2015 mEYE World Photographic Competition
          • 2014 mEYE World Photographic Competition
          • 2013 mEYE World Photographic Competition
          • 2012 mEYE World Photographic Competition
        • Meet Mac De Gen
        • Television and radio
          • 2014 Macular Degeneration Advertising Campaign
        • Keep on Driving Safely campaign
        • World Sight Day
        • Vision Van
      • Education
      • Support Services
      • Research
      • Representation
        • Submissions
          • Archived submissions
        • Reports
          • Low Vision, quality of life and independence: Aids and Technologies review (2016)
          • Economic Impact of Diabetic Macular Oedema (2015)
          • Client Services Evaluation (Annual)
          • Ripple Effect of Vision Loss (2013)
          • Global Ageing & Vision Summit (2013)
          • Angiogenesis Foundation Paper (2012)
          • Eyes on the Future (2011)
          • Archived reports
        • Campaigns
          • Federal Election 2016
          • NDIS & Aged Care Reform
          • Commonwealth Home Support
          • Archived Campaigns
            • Diabetic macular edema
            • Pin-only credit cards
            • South Australian hospital crisis
            • Sight for Seniors
    • Support Us
      • Donate
      • Bequests
        • Enquire about Leaving a Bequest
      • Fundraise
        • Larapinta Challenge 2018
        • 50 Good Reasons to support Macular Degeneration
        • Enquire About Fundraising
      • Volunteer
        • Become a volunteer
      • Friends of the Foundation
        • Val Nicholson
        • Shane Dunbar-Reid
        • Helen Siemering
        • Life in lockdown: Nancy
        • Susan Harvey
        • Mel Byrnes
        • Denis Sutton
        • Alicia Thompson
        • The earlier the better: Jessica Falon
        • Life in lockdown: Jim
        • Life in lockdown: Val
        • Through Her Eyes: A Tribute
        • Generational blindness from AMD
        • AMD: Know your family risk
        • A life changing, art changing diagnosis of AMD
        • Erin Philpot
        • Jean and Elaine Kittson
        • Nancy Little
        • Amanda Little
        • Cheryl O’Reilly
        • Anne Ness
        • Become a Friend of the Foundation
      • Sponsors and Supporters
        • Enquire About Supporting the Foundation
      • Professional Friends
        • Become a Professional Friend - Ophthalmologists
        • Become a Professional Friend - Optometrists
    • Contact Us

    Archived submissions

     

    Macular Disease Foundation Australia presents submissions to government aimed at improving quality of life for people living with a macular disease, their families and carers. Read archived submissions here.

    2015 Submissions

    During 2015, the Foundation made representations on behalf of the macular disease community:
     

    MBS Item: Optical Coherence Tomography (OCT) Reimbursement

    November 2015
     
    The Foundation made recommendations to the Federal Government regarding a new Medicare Benefits Schedule item, which would allow consumers to be reimbursed for Optical Coherence Tomography. OCT is a non-invasive imaging test that uses light waves to take cross-sectional images of the retina. These images are used by eye health professionals to detect, diagnose and provide treatment guidance for eye diseases including macular degeneration and diabetic eye disease. The inclusion of OCT on the Medicare Benefits Schedule has been an ongoing campaign for Macular Disease Foundation Australia.
     

    Independent Review of the Operation of the National Disability Insurance Scheme Act (Commonwealth)

    October 2015
     
    The Foundation highlighted concerns to the Federal Government Department of Health regarding access to the National Disability Insurance Scheme for people who acquire a disability such as vision loss after the age of 65 and for those with early stage vision loss. The Foundation’s aim is to ensure people who acquire a disability after 65 years of age and those with early stage vision loss receive appropriate access to affordable treatments as well as low vision technologies and services that support independent living.
     

    Private Health Insurance

    October 2015
     
    The Australian Competition and Consumer Commission’s (ACCC) annual report to the Australian Senate on anti-competitive practices by health insurers and providers in relation to private health insurance (Oct 2015), stated “there are a number of market failures in private health insurance and there are increasing policy limitations and exclusions leading to an increased risk of unexpected out-of-pocket expenses and general dissatisfaction with the system”. The Federal Minister for Health announced a review of private health insurance with Professor Graeme Samuel AC appointed to conduct a series of industry and consumer representative roundtables to identify reform options to enhance the value of private health insurance for consumers. At a consumer roundtable the Foundation highlighted aspects of a ‘broken system’ that requires urgent fixing, especially with respect to injections for wet macular degeneration and access to low vision aids and technologies.
     

    Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines

    September 2015
     
    The Federal Government Department of Health reviewed the Pharmaceutical Benefits Advisory Committee Guidelines to ensure assessment processes were consistent, transparent and continue to address contemporary methodological issues associated with the Pharmaceutical Benefits Scheme. The Foundation recommended to the Department of Health a range of amendments be included in the Pharmaceutical Benefits Advisory Committee Guidelines to support access and equity to treatment for macular diseases.
     

    National Priorities for Clinical Practice Guidelines 2015

    September 2015
     
    The Foundation made recommendations to the Australian Commission on Safety and Quality in Health Care regarding the establishment of the National Priorities for Clinical Practice Guidelines 2015. Concerns were voiced because although clinical practice guidelines were included for diabetic retinopathy, there were no guidelines for age-related macular degeneration.
     

    Chronic and Complex Health Conditions through Primary Care

    September 2015
     
    The Primary Health Care Advisory Group investigated and reported on best practice in prevention and management of chronic conditions in primary care. As part of this process, the Foundation participated in a survey investigating options to provide better care for people with complex and chronic illness, such as age-related macular degeneration and diabetic eye disease, including funding options, and improved connection between primary health care and hospital care.
     

    Medicare Benefits Scheme Review

    September & November 2015
     
    The Federal Government announced a comprehensive review of all Medicare procedures to assess their evidence base, relevance and costs. This review included intravitreal injections for the treatment of some macular diseases. At consultation meetings held as part of this review process, the Foundation highlighted the ongoing need to provide affordable access to effective treatments for macular diseases. The Foundation voiced its concern that attempts to reduce costs may result in ‘cost shifting’ with additional financial burden being placed on patients.
     

    Attorney General’s National Interest Analysis on the Marrakesh Treaty

    July 2015
     
    The Marrakesh Treaty aims to provide people around the world who are blind, visually impaired, and otherwise print disabled with equal access to information and communications, enabling them to exercise the right to freedom of expression and opinion. The Foundation reviewed, and strongly supported, the Federal Government’s intended legislative changes to ratify the Marrakesh Treaty when it was released for consultation.
     

    Home Care Packages User Rights Consumer Directed Care Amendments

    May 2015
     
    The Foundation recommended amendments to Home Care Packages operating on a Consumer Directed Care basis, (implemented 1 July 2015), which enable consumers to choose, in partnership with providers, the services they acquire. The submission aimed to ensure fairness and equity for all consumers accessing the program, taking into account cultural, linguistic and religious preferences and ensuring those lacking decision making capacity had access to representation.
     

    Drug Utilisation Sub Committee (DUSC) Review of Anti-VEGF Treatment

    May 2015
     
    The Foundation provided the Drug Utilisation Sub Committee (DUSC) of the Federal Government’s Pharmaceutical Benefits Advisory Committee with information related to anti-VEGF treatment for macular degeneration. This advice added to DUSC members’ understanding of treatment protocols, outcomes and challenges faced in treatment delivery.
     

    National Diabetes Strategy Consultation Paper

    May 2015
     
    The Foundation made recommendations to the Government for a national diabetes strategy. These related to public and professional awareness and education surrounding diabetic eye disease (including awareness of low vision as a significant cause of depression), as well as access to support services and affordable treatment. The Foundation recommended improved referral pathways between GPs, optometrists, ophthalmologists and low vision agencies, and also recommended a specific Medicare Benefits Schedule Item number for anti-VEGF treatment of diabetic macular edema.

     

    Building Access

    April 2015
     
    The Foundation recommended to the Australian Building Codes Board (ABCB) that building access is improved for people with low vision or blindness, including access to emergency egress.
     

    Community Home Support Programme

    April 2015
     
    The Foundation made recommendations to the Federal Government regarding the proposed Community Home Support Programme (CHSP) fees policy, highlighting the risk that, under the proposed policy, some consumers may experience an increase in fees for the services received.  
    Additionally the Foundation recommended amendments to the CHSP Programme Manual 2015, Guidelines and CHSP Good Practice Guide to include specific reference to low vision assistive technology for people with age-related macular degeneration. These recommendations were accepted and implemented.
    The Foundation’s aim is to ensure older people with a disability, in the aged care system, have the same access to affordable low vision assistive technology as younger people with a disability in the National Disability Insurance Scheme. This recognises that assistive technology maximises independence and autonomy for those with low vision.
     

    Expert Review of Complementary Medicines Regulations

    April 2015
     
    The Foundation made a submission to the Therapeutic Goods Administration’s review of Australian regulatory guidelines for complementary medicines and was invited to meet with the expert panel comprising Professor John Horvath AO, Emeritus Professor Lloyd Samson AO and Mr Will Delaat AM. Professor Paul Mitchell and Foundation representatives addressed the expert panel on key issues related to access to complementary medicines with level one evidence.
     

    NDIS Tier 2 Policy Framework on Information, Linkages and Capacity Building (ILC)

    March 2015
     
    The Information, Linkages and Capacity Building framework aims to improve access to a broad range of services, via referral, for all people, regardless of age or level of disability. Included within this framework is the funding of episodic specialist assessments, specialist disability training and some assistive technology. The Foundation advised the Federal Government on the impact ILC will have on people with vision impairment or blindness, and requested greater detail of the proposed framework with regard to consumer eligibility and services provided within the ILC. The Foundation voiced concerns that adequate funding had not been allocated to ILC and that consumers may be required to make a co-payment to access services.
     

    National Disability Insurance Agency Assistive Technology Discussion Paper

    February 2015
     
    The Foundation voiced concerns regarding the National Disability Insurance Agency’s (NDIA) procurement policy, which threatened to limit access to the most appropriate assistive technology and increase costs for consumers.
     

    Ozurdex for Pseudophakic Diabetic Macular Edema (DME) Patients

    February 2015
     
    The Foundation submitted comment to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the proposed listing of Ozurdex implant for diabetic macular edema in pseudophakic people (those who have had cataracts removed). In February 2016 the Foundation submitted a second submission supporting the Pharmaceutical Benefits Scheme (PBS) listing of Ozurdex, highlighting the benefits for particular patient groups.
     

    2015-16 Pre-budget Submission

    February 2015
     
    The Foundation proposed Federal Government funding for its Helpline, support services, education and awareness campaigns, aligning its programs with the Commonwealth Government’s National Framework for Action to Promote Eye Health and Prevent Avoidable Blindness and Vision Loss. The submission highlighted that the Foundation’s services and programs reduce the incidence and impact of macular disease and in doing so, generate significant savings for the nation.
     

    Accessibility to Information

    January 2015
     
    The Foundation successfully advocated for improved readability of forms and statements generated by an Australian energy provider with the aim of achieving greater accessibility of documents for people with low vision.
     
     

    2014 Submissions

    Low Vision Aids and Technologies

    December 2014

    The Foundation advocated on behalf of its constituents for improved benefits for low vision aids and technology from private health funds. Through a consumer-focussed campaign, the Foundation also improved awareness of those private health funds that provide appropriate benefits.

     

    Senate Selection Committee on Health

    October 2014

    The Foundation presented a comprehensive submission to the Senate Select Committee on Health that addressed numerous significant issues that affect consumers with low vision including:

    • Access and availability of public hospital outpatient treatment
    • Out-of-pocket treatment costs
    • Health promotion, prevention and early intervention for macular disease
    • Eye checks in residential aged care facilities
    • The need for patients with diabetes to have two-yearly checks or annual checks if there is evidence of retinopathy.
    • Gaps in the ophthalmology workforce
    • Access to low vision aids and technologies expenditure.

    Commonwealth Home Support Programme (CHSP) Key Directions

    June 2014
     
    The Foundation made recommendations in the development of the CHSP. These recommendation included recognition of "People with disability" as a special needs group in the Aged Care Act 1997, the establishment of an aged care and disability care system interface as a key design element, increasing the goods and equipment (including low vision aids) funding cap from $500 to $1,000, and developing an appropriate funding mechanism for aids and equipment costing over $1,000.
     

    Senate Inquiry on out-of-pocket costs in Australian healthcare

    June 2014
     
    The Foundation provided a submission to the Senate Inquiry investigating the impacts of out-of-pocket healthcare costs in Australia. The Foundation’s submission included recommending Medicare reimbursements for anti vascular endothelial growth factor (anti-VEGF) treatment drugs, ocular coherence tomography (OCT) scans, supplements conforming to the Age-Related Eye Disease Study 2 (AREDS2) formulation, improving rebates for optometry eye check-ups, greater financial support for long distance travel to treatment, and further consideration to impact of the proposed $7 GP co-payment.
     

    2014-15 Pre-budget Submission

    January 2014
     
    The Foundation provided a submission that comprehensively detailed the need for the Commonwealth Government to support the Macular Disease Foundation Australia Helpline in the 2014-15 Budget.
     

     

    Share this article
    Select Your Type?
     
     
     
    • Home
    • Macular Disease
    • Research
    • Resources
    • News & Events
    • Foundation

    Contact Us

    1800 111 709
    [email protected]
    Suite 902, Level 9, 447 Kent Street, Sydney 2000

    Follow Us

    acnc_logo_reverse.png


    Helpline 1800 111 709

    Donate

    Macular Disease Foundation Australia ABN 52096255177
    • Privacy Policy
    • Site Map
    • Terms & Conditions
    • Disclaimer